@article{82eaa9ef3f3540d396bc957587ae907c,
title = "Re: Jochen Walz. The “PROMIS” of Magnetic Resonance Imaging Cost Effectiveness in Prostate Cancer Diagnosis? Eur Urol 2018;73:31–2",
author = "Rita Faria and Soares, \{Marta O.\} and Eldon Spackman and Ahmed, \{Hashim U.\} and Brown, \{Louise C.\} and Richard Kaplan and Mark Emberton and Sculpher, \{Mark J.\}",
note = "Funding Information: Rita Faria, Marta O. Soares, Eldon Spackman, Louise Brown, Richard Kaplan, and Mark J. Sculpher have no conflicts of interest. Hashim U. Ahmed receives trial funding from Sophiris Biocorp, Trod Medical, and Sonacare Inc., and fees for lectures and proctoring from Sonacare Inc. Mark Emberton receives trial funding from Sophiris Biocorp, Trod Medical, Steba Biotech, Immodulon, and Sonacare Inc.; fees for lectures and proctoring from Sonacare Inc.; and consulting fees from Sonacare Inc., Steba Biotech, and Sophiris Biocorp. Mark Emberton has shares in Nuada Medical Ltd.",
year = "2018",
month = jun,
doi = "10.1016/j.eururo.2018.02.003",
language = "English",
volume = "73",
pages = "e151--e152",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier B.V.",
number = "6",
}